How To Use RWE To Optimize P&R Of New Health Technologies

October 4, 2018 Danielle Twigg

Educational poster presented at ISPOR Meeting, Barcelona, November 2018

Previous Article
NICE And The Cancer Drugs Fund – Can Observational Evidence Inform Funding Decisions In Oncology?
NICE And The Cancer Drugs Fund – Can Observational Evidence Inform Funding Decisions In Oncology?

Next Article
Real World Evidence: Does The Popularity Of The Term Reflect In Publication Numbers?
Real World Evidence: Does The Popularity Of The Term Reflect In Publication Numbers?